Advantages of doxapram for post-anesthesia recovery and outcomes in bariatric surgery patients.

Phase 2

Recruiting

• Conditions: Morbid obesity; Morbid obesity.

• Registration Number: IRCT2017060712203N9
• Lead Sponsor: Shahid Modarrs Hospital, Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 26

Inclusion Criteria

patients with ASA Class I, II; body mass index over 45; patients with a history of OSA; smokers; the patient consent to participate in the plan. Exclusion criteria: use of drugs; cardiac diseases; the cause of longer than 3 hours surgery or surgical complications occur.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The timing of the return of spontaneous breathing after the injection reverse dose in doxapram group and the control group. Timepoint: since revers dose of muscular blocker until spontaneous respiration. Method of measurement: With the clock.

Secondary Outcome Measures

Name	Time	Method
Train-of-four monitor to determine the recovery time after the reverse dose doxapram group and the control group. Timepoint: Since reversal dose of muscular blocker until return muscular blockage. Method of measurement: With the train-of-four monitor.;End Tidal Co2 determine the reverse dose doxapram group and the control group in 5 minutes. Timepoint: Every 5 minute. Method of measurement: Capnograhpy.